RxDoctor Payments Data

Robert Lentz, MD

Anesthesiology · Greenacres, FLNPI 1720001225

Payments from drug & device makers

$855in general payments, 2019–2025

Across 41 payments — averaging $20.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$287
  • AbbVie$174
  • Vertos Medical, Inc.$142
  • Protega Pharmaceutials Inc$76
  • Collegium Pharmaceutical, Inc.$57
  • Forte Bio-pharma LLC$33
  • plus $86 from 4 others

What the payments were for

  • Food & beverage$855100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$855 in reported general payments places this provider in the 80th percentile of 2,767 anesthesiology providers in Florida.

See all anesthesiology providers in Florida

Medicare billing

Part B allowed, 2024
$119,332
Medicare patients
190
Services billed
3,571

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate420$318,637
OxycontinOxycodone Hcl169$186,792
PercocetOxycodone Hcl/Acetaminophen27$83,889
NucyntaTapentadol Hcl38$79,181
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,870$58,551
Morphine Sulfate ErMorphine Sulfate1,226$46,424
Oxycodone Hcl1,745$37,281
Fentanyl220$32,460
Fentanyl Citrate13$27,500
Oxymorphone Hcl ErOxymorphone Hcl29$22,268
Nucynta ErTapentadol Hcl13$13,601
Morphine Sulfate313$11,162
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen567$11,073
Diclofenac Sodium871$10,595
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl69$10,346

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta, Nucynta Er, Belbuca$57$419,945489 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,767 anesthesiology providers in Florida.

Other anesthesiology in Greenacres

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →